Answer:
Humans are responsible for the environmental pollution in many ways . Some of the points are as follows :
1 ) People throw the wastes wherever they like instead of using dustbins .
2 ) The various types of gases from the industries which harms the nature .
3 ) Cutting off the trees . ( people can cut but also must plant a new one )
4 ) Farmers using different chemical substances in high amount in the crops .
5 ) Burning plastics , tires etc .
This was my way to answer the question , if you need then you can write in paragraph .
let me know if its incorrect . :-)
Answer:
You tell her that this is incorrect.
Explanation:
The given information is incorrect as both small and large ribosomal subunits are required for protein synthesis. The eukaryotic ribosomes have E, P, and A sites. The A and P sites bind to the aminoacyl tRNA that carry the amino acid encoded by the codon of the mRNA.
The formation of peptide bond occurs between the amino group of amino acid in A site and the carboxyl group of amino acid present on P site. Both 40S and 60S subunit of ribosome contribute the A and P sites.
I believe <span>Erta Ale from Ethiopia, Hekla from Iceland, and Ol Doinyo Lengai from Congo.
Hope this helps!</span>
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
